| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8955863 | International Journal of Radiation Oncology*Biology*Physics | 2018 | 9 Pages |
Abstract
This study confirms that, based on changes in bowel and urinary domains and toxicity (acute and late), the 5- and 12-fraction regimens are well tolerated. These ultrahypofractionated approaches need to be compared with current standard radiation therapy regimens.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Himanshu R. MD, Stephanie L. PhD, Deborah W. PhD, Jean-Paul MD, Colleen A.F. MD, Jason A. MD, Rajat J. PhD, Lee E. MD, Samantha A. MD, Ian S. MD, Darindra D. MD, Jeff M. MD, Guila MD, Irving D. MD, Eric M. MD, Mack MD, Wayne H. DO, David C. MD,